• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Neuralstem Inc

+ Add to Watchlist

CUR:US

2.7800 USD 0.0900 3.14%

As of 14:19:35 ET on 10/31/2014.

Snapshot for Neuralstem Inc (CUR)

Open: 2.9600 Day's Range: 2.7500 - 2.9600 Volume: 244,902
Previous Close: 2.8700 52wk Range: 2.1200 - 4.8099 1-Yr Rtn: +24.66%

Stock Chart for CUR

No chart data available.
  • CUR:US 2.7800
  • 1D
  • 1M
  • 1Y
2.8700
Interactive CUR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CUR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2860
Est. EPS (USD) (12/2014) -0.2300
Est. PEG Ratio -
Market Cap (M USD) 243.14
Shares Outstanding (M) 86.84
30 Day Average Volume 633,525
Price/Book (mrq) 10.0467
Price/Sale (ttm) 16,122.7861
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CUR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CUR

Neuralstem Inc. provides medical research services. The Company develops and commercializes clinical treatment for central nervous system diseases. Neuralstem serves the medical field worldwide.

Karl JoheChairman/Chief Scientific OfcrI Richard GarrPresident/CEO/CFO/Gen Counsel
Thomas Hazel "Tom"Senior VP:ResearchSusan RoushInvestor Relations
More Company Profile & Key Executives for CUR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil